Related Experiment Videos
Peripheral bone density in women with untreated multinodular goitre
A H Mudde1, F J Reijnders, A C Kruseman
1Department of Internal Medicine, Slingeland Ziekenhuis, Doetinchem, The Netherlands.
Clinical Endocrinology
|July 1, 1992
Summary
Women with subclinical hyperthyroidism and multinodular goitre have reduced forearm bone density. This study highlights a potential link between thyroid function and bone health in women with goitre.
Area of Science:
- Endocrinology
- Bone Metabolism
- Thyroid Disorders
Background:
- Multinodular goitre is a common thyroid condition.
- Subclinical hyperthyroidism, characterized by suppressed TSH with normal free T4 and T3, can affect various physiological processes.
- Bone density assessment is crucial for evaluating fracture risk.
Purpose of the Study:
- To investigate the relationship between subclinical hyperthyroidism in women with multinodular goitre and bone mineral density.
- To compare bone density in women with subclinical hyperthyroid goitre versus euthyroid goitre.
Main Methods:
- Bone density was measured at the distal and proximal forearm using single photon absorptiometry.
- Subjects included 23 women with subclinical hyperthyroid goitre and 54 women with euthyroid goitre, compared to 125 age- and menopause-matched controls.
- Thyroid stimulating hormone (TSH), free thyroxine (FT4), and total triiodothyronine (T3) levels were measured.
Main Results:
- Women with subclinical hyperthyroid goitre exhibited significantly lower Z-scores for both distal and proximal forearm bone density compared to those with euthyroid goitre.
- Median FT4 levels were higher in the subclinical hyperthyroid group, though still within the normal range.
- A significant inverse correlation was observed between FT4 levels and forearm bone density in the subclinical hyperthyroid group.
Conclusions:
- Untreated multinodular goitre associated with subclinical hyperthyroidism leads to reduced bone density in the forearm.
- These findings suggest that even mild thyroid overactivity can negatively impact bone health.
- Further research is warranted to explore the clinical implications and management strategies for bone loss in this patient population.